Delivery Order SPE2DB20D2001-SPE2DB23FM71F
- Not listed
- This federal contract award, valued at $1,854.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SHINGRIX VIAL KITS, a critical vaccine product, to support federal government healthcare programs. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,228.41 for SHINGRIX VIAL KITS. The contract was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of May 1, 2024. The contract is a firm-fixed-price delivery order and was not set aside for any specific business type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that supplies a wide range...
- This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $11,040.80, is for the delivery of SHINGRIX Vial Kits, a pharmaceutical product. The delivery order has a firm fixed price pricing type and a completion date of March 13, 2024. Amerisourcebergen Drug Corp, as a major pharmaceutical distributor, has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., provides for the delivery of SHINGRIX vaccine kits to the Defense Logistics Agency (DLA), an agency of the Department of Defense. The $36,146.40 firm-fixed-price delivery order was issued under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of SHINGRIX vaccine kits. The $27,109.80 Firm Fixed Price Delivery Order has an ultimate completion date of December 17, 2021. Amerisourcebergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- This federal contract award, valued at $13,404.23, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SHINGRIX VIAL KITS, a medical product, with an ultimate completion date of April 7, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., and the contract is structured as a Delivery Order under a larger Indefinite Delivery...
- This federal contract award, valued at $5,345.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SHINGRIX VIAL KITS, a vaccine product. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $42,919.50 firm fixed-price delivery order is for the supply of SHINGRIX vial kits, a pharmaceutical product, with an ultimate completion date of January 4, 2024. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of SHINGRIX VIAL KITS under Contract ID SPE2DX15D1022|SPE2DX23FVFHW. The $74,186.30 Firm Fixed Price delivery order has a completion date of March 17, 2023 and was awarded on March 16, 2023 by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of SHINGRIX vaccine kits. The award, valued at $3,207.03, is a firm fixed-price delivery order contract with an ultimate completion date of August 1, 2023. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle for providing a...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB23FM71FDelivery Order
This federal contract award, valued at $5,345.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of SHINGRIX vaccine kits and has a completion date of September 6, 2023. It is a firm fixed-price delivery order contract, and no set-aside designation was used. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that supplies a wide range of medical products, including specialty medications, generic drugs, and other healthcare commodities, to federal government agencies. The company holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing pharmaceutical and medical supplies to support military healthcare programs globally. Additionally, Amerisourcebergen Drug Corp maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 9/5/23 |